Basic Stats
Insider Profile CAXTON CORP
Portfolio Value $ 9,853,131
Current Positions 11
Latest Holdings, Performance, AUM (from 13F, 13D)

Caxton Corp has disclosed 11 total holdings in their latest SEC filings. Most recent portfolio value is calculated to be $ 9,853,131 USD. Actual Assets Under Management (AUM) is this value plus cash (which is not disclosed). Caxton Corp’s top holdings are Rezolute, Inc. (US:RZLT) , SPDR Gold Trust (US:GLD) , Berkshire Hathaway Inc. (US:BRK.B) , Enliven Therapeutics, Inc. (US:ELVN) , and Mind Medicine (MindMed) Inc. (US:MNMD) . Caxton Corp’s new positions include Enliven Therapeutics, Inc. (US:ELVN) , .

Caxton Corp - Portfolio Value
Top Increases This Quarter

We use the change in the portfolio allocation because this is the most meaningful metric. Changes can be due to trades or changes in share prices.

Security Shares
(MM)
Value
(MM$)
Portfolio % ΔPortfolio %
0.00 1.51 15.3204 7.9573
0.01 0.26 2.6665 2.6665
Top Decreases This Quarter

We use the change in the portfolio allocation because this is the most meaningful metric. Changes can be due to trades or changes in share prices.

Security Shares
(MM)
Value
(MM$)
Portfolio % ΔPortfolio %
1.60 7.15 72.6041 -2.6797
0.00 0.31 3.1162 -1.7810
0.01 0.10 1.0316 -1.7743
0.03 0.22 2.2443 -1.6789
0.00 0.00 -0.8212
0.02 0.07 0.7071 -0.5120
0.04 0.11 1.1469 -0.4785
0.02 0.03 0.3244 -0.3822
0.02 0.07 0.7160 -0.1569
0.02 0.01 0.1224 -0.0993
13F and Fund Filings

This form was filed on 2025-08-14 for the reporting period 2025-06-30. Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

2022-07-28: Important Note - We have changed the treatment of the Δ Portfolio % column in this table. Previously, we were reporting it as the percent change in the portfolio allocation. We are now reporting it as the raw change in the portfolio allocation (still reported as a percent). In formula terms, we were previously reporting it as 100 * (current allocation - prior allocation ) / prior allocation. We are now reporting it as (current allocation - prior allocation).
Security Type Avg Share Price Shares
(MM)
ΔShares
(%)
ΔShares
(%)
Value
($MM)
Portfolio
(%)
ΔPortfolio
(%)
RZLT / Rezolute, Inc. 1.60 21.61 7.15 87.01 72.6041 -2.6797
GLD / SPDR Gold Trust 0.00 281.51 1.51 303.48 15.3204 7.9573
BRK.B / Berkshire Hathaway Inc. 0.00 35.33 0.31 23.79 3.1162 -1.7810
ELVN / Enliven Therapeutics, Inc. 0.01 0.26 2.6665 2.6665
MNMD / Mind Medicine (MindMed) Inc. 0.03 0.00 0.22 11.06 2.2443 -1.6789
CMPX / Compass Therapeutics, Inc. 0.04 0.00 0.11 37.80 1.1469 -0.4785
BCAX / Bicara Therapeutics Inc. 0.01 0.00 0.10 -28.87 1.0316 -1.7743
KYTX / Kyverna Therapeutics, Inc. 0.02 0.00 0.07 59.09 0.7160 -0.1569
LXEO / Lexeo Therapeutics, Inc. 0.02 -2.91 0.07 13.11 0.7071 -0.5120
IKT / Inhibikase Therapeutics, Inc. 0.02 0.00 0.03 -11.43 0.3244 -0.3822
CNTX / Context Therapeutics Inc. 0.02 0.00 0.01 9.09 0.1224 -0.0993
CRDF / Cardiff Oncology, Inc. 0.00 -100.00 0.00 -100.00 -0.8212
ACET / Adicet Bio, Inc. 0.00 -100.00 0.00 0.0000